Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › DRREDDY

DRREDDY

Dr. Reddy's Laboratories Limited
Mid-capPharma ↗

What the six lenses say about DRREDDY — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹1144.2
2026-09-08
VWAP · 1Y anchor
₹1259
-9.1% from VWAP
P/E · TTM
22.8×
TTM EPS ₹50.3
52-week range
4%
position low→high
RSI(14)
37
momentum

Own sector index

Pharma ↗
Overweight

1M

+0.4%

3M

+10.5%

1Y

+22.0%

Breadth >EMA21

56%

How DRREDDY’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
6.0
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Mid-cap cohortDRaw
TechnicalD23›

The actual numbers

Price vs VWAP (1y)-9.1%
EMA trend stackDown · 21<50<200
Price vs 200-EMA-7.9%
Price vs 50-EMA-4.6%
RSI(14)37
RS vs Nifty 500 · 3M-14.7%
RS vs sector · 3M-20.8%
52-week range4%
Volume vs 30d avg0.41×
Volume vs 60d avg0.29×
ATR(14) · volatility21.3
Bollinger width · vol contraction0.058
FundamentalD241›

The actual numbers

Return on equity (ROE)11.8%
Return on capital (ROCE)13.6%
Operating margin17.1%
Net margin12.3%
Revenue growth · YoY+3.2%
EPS growth · YoY-62.7%
Debt / equity0.20×

Full 8-quarter history in the financials table below.

ValuationD957›

The actual numbers

P/E (TTM)22.8×
TTM EPS₹50.3
52-week range4%
CatalystD647›

The actual numbers

Earnings & momentum51
Capital actions12
Governance161

Every filing in the corporate-announcements panel below.

FlowD1068›

The actual numbers

Promoter holding26.6%
Delivery · 30d avg55.9%
Up/down-day asymmetry5.0pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D2 + D10 ) ÷ 2 = 6.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Below threshold
9
Conviction score 9/100 · avg-decile strength 6.0/10
Conviction score9/100›
TechnicalD2›
FundamentalD2›
ValuationD9›
CatalystD6›
FlowD10›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
-0.1pp
+0.4pp
+1.2pp
-13.1pp
-9.5pp
-4.5pp
Nifty 500
Broad-market baseline
-0.2pp
+0.4pp
+0.1pp
-14.7pp
-15.2pp
-9.7pp
Sector
Own-sector index
—
—
-2.7pp
-20.8pp
-28.4pp
-30.5pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

DRREDDY daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
1144.20-6.80

Relative strength

RS vs baseline · rebased to 100

DRREDDY ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
87.24-0.15

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)7,6968,0388,3818,5288,5728,8288,7537,546
↳ change QoQ—+4.4%+4.3%+1.8%+0.5%+3.0%-0.8%-13.8%
EBITDA (₹cr)2,3172,3842,4231,9982,1742,0101,888382
EBITDA margin30.1%29.7%28.9%23.4%25.4%22.8%21.6%5.1%
PAT (₹cr)1,3921,3421,4041,5871,4101,3371,190221
↳ change QoQ—-3.6%+4.6%+13.0%-11.2%-5.2%-11.0%-81.4%
Net margin18.1%16.7%16.8%18.6%16.4%15.1%13.6%2.9%
EPS (₹)83.6115.0816.9719.0916.9916.1414.502.65
D/E————————
YoY growth · Mar '26Revenue -11.5% YoYPAT -86.1% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 26 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 14 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 14 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Aug '26
    MEDIUMgovernance
    Resignation of Director/KMP/SMP
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Aug '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 7 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 1 Aug '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 29 Jul '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Jul '26
    LOWgovernance
    News Verification
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 Jul '26
    LOWgovernance
    News Verification
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 Jul '26
    HIGHgovernance
    Change in Auditors
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 Jul '26
    MEDIUMgovernance
    Change in Director(s)
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 Jul '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 22 Jul '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds DRREDDY

Mutual funds holding DRREDDY (10)

FundWeightAUM ₹crGrade
Parag Parikh Flexi Cap Reg Gr1.11%1,48,429
ICICI Prudential Large Cap Instl I Gr0.80%80,962
ICICI Prudential Large Cap Gr0.80%80,962
Nippon India Large Cap Gr0.85%54,225
Nippon India Large Cap Dir Bns0.85%54,225
Nippon India Large Cap Instl Bns0.85%54,225
Nippon India Large Cap Bns0.85%54,225
Mirae Asset Large Cap Reg Gr0.53%38,729
Bandhan Large & Mid Cap Gr0.54%19,777
Nippon India Flexi Cap Reg Gr0.65%9,710

ETFs holding DRREDDY (10)

ETFWeightGrade
Nippon India Nifty Pharma ETF7.07%
DSP Nifty Healthcare ETF6.10%
Axis NIFTY Healthcare ETF6.08%
Aditya BSL Nifty Healthcare ETF6.08%
ICICI Pru Nifty Healthcare ETF6.08%
Mirae Asset Nifty 500 Healthcare ETF5.03%
Motilal Oswal BSE Healthcare ETF4.34%
DSP BSE Sensex Next 30 ETF2.67%
Nippon India BSE Sensex Next 30 ETF2.60%
Groww Nifty 500 Low Volatility 50 ETF1.97%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma